Search research articles
Contact Us
Filters
Showing results (281-290 of 910) with videos related to
Page
of 91
Sort By:
European Heart Journal
|
January 13, 2006
Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction
Wei-Ching Chang, Padma Kaul, Yuling Fu, et al.
American Heart Journal
|
March 5, 2013
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
Cynthia M Westerhout, Karen S Pieper, Stefan K James, et al.
European Journal of Heart Failure
|
December 2, 2017
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure
Emil Wolsk, Brian Claggett, Lars Køber, et al.
European Journal of Heart Failure
|
July 19, 2016
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme
Kevin Damman, Scott D Solomon, Marc A Pfeffer, et al.
Lancet (London, England)
|
September 19, 2003
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, et al.
American Heart Journal
|
March 30, 2006
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction
Paul W Armstrong, Kenneth W Mahaffey, Wei-Ching Chang, et al.
European Heart Journal
|
November 13, 2008
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure
Putte Abrahamsson, Joanna Dobson, Christopher B Granger, et al.
European Heart Journal
|
November 7, 2008
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme
Alain Cohen-Solal, John J V McMurray, Karl Swedberg, et al.
Coronary Artery Disease
|
January 6, 2012
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction
James S Mills, Kenneth W Mahaffey, Yuliya Lokhnygina, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 17, 2022
Targeted temperature management after out of hospital cardiac arrest: quo vadis?
Konstantin A Krychtiuk, Christopher B Fordyce, Carolina M Hansen, et al.
Page
of 91
Search research articles
Search
Showing results (281-290 of 910) with videos related to
Sort By:
Page
of 91
European Heart Journal
|
January 13, 2006
Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction
Wei-Ching Chang, Padma Kaul, Yuling Fu, et al.
American Heart Journal
|
March 5, 2013
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
Cynthia M Westerhout, Karen S Pieper, Stefan K James, et al.
European Journal of Heart Failure
|
December 2, 2017
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure
Emil Wolsk, Brian Claggett, Lars Køber, et al.
European Journal of Heart Failure
|
July 19, 2016
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme
Kevin Damman, Scott D Solomon, Marc A Pfeffer, et al.
Lancet (London, England)
|
September 19, 2003
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, et al.
American Heart Journal
|
March 30, 2006
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction
Paul W Armstrong, Kenneth W Mahaffey, Wei-Ching Chang, et al.
European Heart Journal
|
November 13, 2008
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure
Putte Abrahamsson, Joanna Dobson, Christopher B Granger, et al.
European Heart Journal
|
November 7, 2008
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme
Alain Cohen-Solal, John J V McMurray, Karl Swedberg, et al.
Coronary Artery Disease
|
January 6, 2012
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction
James S Mills, Kenneth W Mahaffey, Yuliya Lokhnygina, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 17, 2022
Targeted temperature management after out of hospital cardiac arrest: quo vadis?
Konstantin A Krychtiuk, Christopher B Fordyce, Carolina M Hansen, et al.
Page
of 91